Skip to main content
. Author manuscript; available in PMC: 2016 Jan 14.
Published in final edited form as: High Blood Press Cardiovasc Prev. 2014 Sep;21(3):205–211. doi: 10.1007/s40292-013-0031-2

Table 3.

Results of multivariate modeling for risk factors for diastolic dysfunction progression

Effect p-value Odds ratio reference Odds ratio 95 % Wald CI
Time to progression observation or total observation time 0.0058 Each additional year of observation 0.567 (0.379, 0.849)
Gender 0.1090 Female vs. male 0.454 (0.173, 1.192)
CCB use 0.1045 Users vs. non users 0.497 (0.173, 1.192)
Diuretic use 0.1945 Users vs. non users 0.599 (0.276, 1.300)
African American 0.0370 AA vs. non-AA 0.411 (0.178, 0.948)
LVH 0.0874 LVH vs. non LVH 2.054 (0.900, 4.690)